Evidence map›Paper›PMID 39649877›Full record

ArticleAnnals of medicine and surgery (2012)2024

Prediction of hospitalization time probability for COVID-19 patients with statistical and machine learning methods using blood parameters.

Kiomars Motarjem, Mahin Behzadifard, Shahin Ramazi, Seyed A H Tabatabaei

Abstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kiomars MotarjemDepartment of Statistics, Faculty of Mathematical Sciences, Tarbiat Modares University.
Mahin BehzadifardDepartment of Medical Laboratory Sciences, School of Paramedical Sciences, Dezful University of Medical Sciences, Dezful.
Shahin RamaziDepartment of Biophysics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran.
Seyed A H TabatabaeiDepartment of Computer Science, Faculty of Mathematical Sciences, University of Guilan, Rasht, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Coronavirus disease 2019 (COVID-19) may induce life-threatening complications and lead to death in the patients. Method: The aim of this study was to describe a predictive model for the disease outcome (length of hospitalization and mortality) by using blood parameters results at the admission time of 201 patients with positive RT-PCR test for the infection. Variables including; age, sex, comorbidity risk factors, the length of hospitalization, and 25 blood parameters results at the time of admission were considered. Results: After analyzing the data, it was observed that several factors, such as hypocalcemia, hyponatremia, red blood cell microcytosis, monocytopenia, thrombocytosis, comorbidity risk factors (diabetes, dialysis, cardiovascular diseases, and hypertension), and age over 50 years had a significant impact on the length of hospitalization and mortality of the patients ( Conclusion: Based on the data analysis, the authors found that the proportional hazard assumption was not established. Therefore, the authors opted to use the accelerated failure time model for our analysis. Among the various models considered, the log-normal model provided the best fit. Considering the analysis of laboratory results at the time of admission, the authors propose that thrombocytosis, red blood cell microcytosis, monocytopenia, hypocalcemia, hyponatremia, comorbidity factors, and age over 50 years can serve as predictive markers for estimating hospitalization length and mortality. These findings suggest that these factors may play a significant role in predicting patient outcomes.

Indexed as

analysiscomorbidityCOVID-19hospitalization days lengthmachine learningSARS-CoV-2

Identifiers

PMID39649877
PMCPMC11623833

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.